2 reports of this reaction
1.9% of all IBUPROFEN AND FAMOTIDINE reports
#5 most reported adverse reaction
RASH is the #5 most commonly reported adverse reaction for IBUPROFEN AND FAMOTIDINE, manufactured by Ascend Laboratories, LLC. There are 2 FDA adverse event reports linking IBUPROFEN AND FAMOTIDINE to RASH. This represents approximately 1.9% of all 108 adverse event reports for this drug.
Patients taking IBUPROFEN AND FAMOTIDINE who experience rash should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
RASH is a less commonly reported adverse event for IBUPROFEN AND FAMOTIDINE, but still significant enough to appear in the safety profile.
In addition to rash, the following adverse reactions have been reported for IBUPROFEN AND FAMOTIDINE:
The following drugs have also been linked to rash in FDA adverse event reports:
RASH has been reported as an adverse event in 2 FDA reports for IBUPROFEN AND FAMOTIDINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
RASH accounts for approximately 1.9% of all adverse event reports for IBUPROFEN AND FAMOTIDINE, making it a notable side effect.
If you experience rash while taking IBUPROFEN AND FAMOTIDINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.